Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination. / Trolle, Simone; Lynggaard, Charlotte Duch; Gregersen, Kristine Grubbe; Baandrup, Louise; Grønhøj, Christian; Buchwald, Christian von.

I: Ugeskrift for Laeger, Bind 181, Nr. 41, V05190279, 2019.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Trolle, S, Lynggaard, CD, Gregersen, KG, Baandrup, L, Grønhøj, C & Buchwald, CV 2019, 'Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination', Ugeskrift for Laeger, bind 181, nr. 41, V05190279. <https://ugeskriftet.dk/videnskab/perspektiver-pa-recidiverende-respiratorisk-papillomatose-og-humant-papillomvirus>

APA

Trolle, S., Lynggaard, C. D., Gregersen, K. G., Baandrup, L., Grønhøj, C., & Buchwald, C. V. (2019). Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination. Ugeskrift for Laeger, 181(41), [V05190279]. https://ugeskriftet.dk/videnskab/perspektiver-pa-recidiverende-respiratorisk-papillomatose-og-humant-papillomvirus

Vancouver

Trolle S, Lynggaard CD, Gregersen KG, Baandrup L, Grønhøj C, Buchwald CV. Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination. Ugeskrift for Laeger. 2019;181(41). V05190279.

Author

Trolle, Simone ; Lynggaard, Charlotte Duch ; Gregersen, Kristine Grubbe ; Baandrup, Louise ; Grønhøj, Christian ; Buchwald, Christian von. / Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination. I: Ugeskrift for Laeger. 2019 ; Bind 181, Nr. 41.

Bibtex

@article{eab64172a2c545d39089ed5e0e8d5f63,
title = "Perspektiver p{\aa} recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination",
abstract = "Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.",
author = "Simone Trolle and Lynggaard, {Charlotte Duch} and Gregersen, {Kristine Grubbe} and Louise Baandrup and Christian Gr{\o}nh{\o}j and Buchwald, {Christian von}",
year = "2019",
language = "Dansk",
volume = "181",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "41",

}

RIS

TY - JOUR

T1 - Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

AU - Trolle, Simone

AU - Lynggaard, Charlotte Duch

AU - Gregersen, Kristine Grubbe

AU - Baandrup, Louise

AU - Grønhøj, Christian

AU - Buchwald, Christian von

PY - 2019

Y1 - 2019

N2 - Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

AB - Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

M3 - Tidsskriftartikel

C2 - 31610833

VL - 181

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 41

M1 - V05190279

ER -

ID: 238526611